Follow
Aurélie Lacroix
Aurélie Lacroix
Senior Scientist II at Sixfold Bioscience (London, UK)
Verified email at sixfold.bio - Homepage
Title
Cited by
Cited by
Year
DNA nanostructures at the interface with biology
KE Bujold, A Lacroix, HF Sleiman
Chem 4 (3), 495-521, 2018
1972018
Uptake and Fate of Fluorescently Labeled DNA Nanostructures in Cellular Environments: A Cautionary Tale
A Lacroix, E Vengut-Climent, D de Rochambeau, HF Sleiman
ACS Central Science, 2019
1552019
Development of DNA nanostructures for high-affinity binding to human serum albumin
A Lacroix, TGW Edwardson, MA Hancock, MD Dore, HF Sleiman
Journal of the American Chemical Society 139 (21), 7355-7362, 2017
1512017
DNA Nanostructures: Current Challenges and Opportunities for Cellular Delivery
A Lacroix, HF Sleiman
ACS Nano, 2021
1112021
Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality
R Szmyd, J Niska-Blakie, MK Diril, P Renck Nunes, K Tzelepis, A Lacroix, ...
Oncogene 38 (7), 998-1018, 2019
642019
Innovative developments and emerging technologies in RNA therapeutics
F Halloy, A Biscans, KE Bujold, A Debacker, AC Hill, A Lacroix, O Luige, ...
RNA Biology 19 (1), 2022
282022
Detailed cellular assessment of albumin-bound oligonucleotides: Increased stability and lower non-specific cell uptake
A Lacroix, HH Fakih, HF Sleiman
Journal of Controlled Release 324, 34-46, 2020
222020
Templated synthesis of spherical RNA nanoparticles with gene silencing activity
MD Dore, JJ Fakhoury, A Lacroix, HF Sleiman
Chemical Communications 54 (80), 11296-11299, 2018
122018
de Rochambeau, HF Sleiman, ACS Cent
A Lacroix, E Vengut, D Climent
Sci 5, 882, 2019
102019
Correction: Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality
R Szmyd, J Niska-Blakie, MK Diril, PR Nunes, K Tzelepis, A Lacroix, ...
Oncogene 39 (9), 2030, 2020
12020
Compositions containing oligonucleotides with theranostic applications
S Werner, JL Rushworth, I Mylonaki, A Lacroix, P Klimkowski, GW Foot, ...
US Patent WO2024069235A2, 2024
2024
RNA Versus Protein, How Structure Influences Targeting, a New Challenge for Drug Discovery
A Bonetti, A Lacroix, E Walsh, A Ghidini
RNA Structure and Function, 119-144, 2023
2023
17th Annual Meeting of the Oligonucleotide Therapeutics Society: A Tribute to Bob Letsinger, Progress in N = 1 Treatments, and Successful First In-Humans CRISPR Trials
RAM Buijsen, A Lacroix, J Ocaba, D O'Reilly, L Abdullahu, EM McConnell, ...
Nucleic Acid Therapeutics 32 (1), 2022
2022
DNA structures at the interface with biology: study and optimization of their outcomes in physiological conditions
A Lacroix
McGill University, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–14